Department of Defense January 9, 2013 – Federal Register Recent Federal Regulation Documents

Intent To Grant an Exclusive License of a U.S. Government-Owned Invention
Document Number: 2013-00226
Type: Notice
Date: 2013-01-09
Agency: Department of Defense, Department of the Army
In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license to the invention claimed in U.S. Patent No. 6,316,197, entitled ``Method of Diagnosing of Exposure to Toxic Agents by Measuring Distinct Pattern in the Levels of Expression of Specific Genes,'' issued on November 13, 2001, and foreign rights to Cascade Biotherapeutics, Inc., with its principal place of business at 4938 Hampden Lane 319, Bethesda, Maryland 20814-2914.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.